Preferences for services in a patient’s first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study

Mhairi Maskew, Vinolia Ntjikelane, Allison Juntunen, Nancy Scott, Mariet Benade, Linda Sande, Pamfred Hasweeka, Prudence Haimbe, Priscilla Lumano-Mulenga, Hilda Shakewelele, Mpande Mukumbwa-Mwenechanya, Sydney Rosen
{"title":"Preferences for services in a patient’s first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study","authors":"Mhairi Maskew, Vinolia Ntjikelane, Allison Juntunen, Nancy Scott, Mariet Benade, Linda Sande, Pamfred Hasweeka, Prudence Haimbe, Priscilla Lumano-Mulenga, Hilda Shakewelele, Mpande Mukumbwa-Mwenechanya, Sydney Rosen","doi":"10.12688/gatesopenres.14682.1","DOIUrl":null,"url":null,"abstract":"<ns4:p><ns4:bold>Background</ns4:bold></ns4:p><ns4:p> </ns4:p><ns4:p> For patients on HIV treatment in sub-Saharan Africa (SSA), the highest risk for loss from care consistently remains the first six months after antiretroviral (ART) initiation, when patients are not yet eligible for most existing differentiated service delivery (DSD) models. To reduce disengagement from care during this period, we must gain a comprehensive understanding of patients’ needs, concerns, resources, and preferences for service delivery during this period. The PREFER study will use a sequential mixed-methods approach to survey a sample of patients in South Africa and Zambia 0-6 months after ART initiation to develop a detailed profile of patient characteristics and needs.</ns4:p><ns4:p> </ns4:p><ns4:p> <ns4:bold>Protocol</ns4:bold></ns4:p><ns4:p> </ns4:p><ns4:p> PREFER is an observational, prospective cohort study of adult patients on ART for ≤6 months at 12 public sector healthcare facilities in Zambia and 18 in South Africa that aims to inform the design of DSD models for the early HIV treatment period. It has four components: 1) survey of clients 0-6 months after ART initiation; 2) follow up through routinely collected medical records for <12 or <24 months after enrollment; 3) focus group discussions to explore specific issues raised in the survey; and 4) in South Africa only, collection of blood samples self-reported naïve participants to assess the prevalence of ARV metabolites indicating prior ART use. Results will include demographic and clinical characteristics of patients, self-reported HIV care histories, preferences for treatment delivery, and predictors of disengagement.</ns4:p><ns4:p> </ns4:p><ns4:p> <ns4:bold>Conclusions</ns4:bold></ns4:p><ns4:p> </ns4:p><ns4:p> PREFER aims to understand why the early treatment period is so challenging and how service delivery can be amended to address the obstacles that lead to early disengagement from care and to distinguish the barriers encountered by naïve patients to those facing re-initiators. The information collected by PREFER will help respond to patients’ needs and design better strategies for service delivery and improve resource allocation going forward.</ns4:p>","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":"27 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gates Open Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/gatesopenres.14682.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background For patients on HIV treatment in sub-Saharan Africa (SSA), the highest risk for loss from care consistently remains the first six months after antiretroviral (ART) initiation, when patients are not yet eligible for most existing differentiated service delivery (DSD) models. To reduce disengagement from care during this period, we must gain a comprehensive understanding of patients’ needs, concerns, resources, and preferences for service delivery during this period. The PREFER study will use a sequential mixed-methods approach to survey a sample of patients in South Africa and Zambia 0-6 months after ART initiation to develop a detailed profile of patient characteristics and needs. Protocol PREFER is an observational, prospective cohort study of adult patients on ART for ≤6 months at 12 public sector healthcare facilities in Zambia and 18 in South Africa that aims to inform the design of DSD models for the early HIV treatment period. It has four components: 1) survey of clients 0-6 months after ART initiation; 2) follow up through routinely collected medical records for <12 or <24 months after enrollment; 3) focus group discussions to explore specific issues raised in the survey; and 4) in South Africa only, collection of blood samples self-reported naïve participants to assess the prevalence of ARV metabolites indicating prior ART use. Results will include demographic and clinical characteristics of patients, self-reported HIV care histories, preferences for treatment delivery, and predictors of disengagement. Conclusions PREFER aims to understand why the early treatment period is so challenging and how service delivery can be amended to address the obstacles that lead to early disengagement from care and to distinguish the barriers encountered by naïve patients to those facing re-initiators. The information collected by PREFER will help respond to patients’ needs and design better strategies for service delivery and improve resource allocation going forward.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在南非和赞比亚,患者接受抗逆转录病毒治疗前6个月的服务偏好(PREFER):一项前瞻性观察队列研究的研究方案
背景:对于撒哈拉以南非洲(SSA)接受艾滋病毒治疗的患者来说,在开始抗逆转录病毒(ART)治疗后的前6个月,患者仍不符合大多数现有差异化服务提供(DSD)模式的条件,因此失去护理的风险最高。为了减少在这一时期脱离护理的情况,我们必须全面了解患者在这一时期的需求、关切、资源和服务提供偏好。PREFER研究将采用顺序混合方法对南非和赞比亚开始抗逆转录病毒治疗后0-6个月的患者样本进行调查,以形成患者特征和需求的详细概况。PREFER方案是一项观察性前瞻性队列研究,在赞比亚的12个公共部门医疗机构和南非的18个公共部门医疗机构中对接受抗逆转录病毒治疗的成人患者进行了≤6个月的研究,旨在为早期艾滋病毒治疗期的DSD模型设计提供信息。它有四个组成部分:1)对开始抗逆转录病毒治疗后0-6个月的客户进行调查;2)通过常规收集入组后12个月或24个月的医疗记录进行随访;3)焦点小组讨论,探讨调查中提出的具体问题;4)仅在南非,收集血液样本,自行报告naïve参与者,以评估表明先前使用抗逆转录病毒药物的ARV代谢物的患病率。结果将包括患者的人口学和临床特征、自我报告的艾滋病毒护理史、对治疗方式的偏好以及脱离治疗的预测因素。PREFER旨在了解为什么早期治疗阶段如此具有挑战性,以及如何修改服务提供以解决导致早期脱离护理的障碍,并区分naïve患者遇到的障碍和面临重新启动的患者。preferred收集的信息将有助于响应患者的需求,设计更好的服务提供策略,并改善未来的资源分配。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gates Open Research
Gates Open Research Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
CiteScore
3.60
自引率
0.00%
发文量
90
期刊最新文献
Developing a framework for understanding policy decision-making behaviors in the transition of an HIV prevention program towards sustainability: a case study from Zambia's voluntary medical male circumcision program. Knowledge and uptake of contraceptive and other sexual reproductive health services among in-school adolescents in three South African townships: Baseline findings from the Girls Achieve Power (GAP Year) Trial. Using models and maps to inform Target Product Profiles and Preferred Product Characteristics: the example of Wolbachia replacement. Vaccine decision-making among pregnant women: a protocol for a cross-sectional mixed-method study in Brazil, Ghana, Kenya and Pakistan. Simulated data for census-scale entity resolution research without privacy restrictions: a large-scale dataset generated by individual-based modeling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1